ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,523Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 151

$3.64M Total Retail Price of All Prescriptions

Rank: 1 out of 151

906 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 906 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

3% of this provider’s 906 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 21,864 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$128 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LIDODERM 809 616 1 65
SIMVASTATIN 760 663 2 1
OMEPRAZOLE 735 634 3 4
ADVAIR DISKUS 726 536 4 46
NEXIUM 715 455 5 44
LISINOPRIL 638 456 6 5
SINGULAIR 581 441 7 72
IBUPROFEN 524 406 8 69
METFORMIN HCL 487 385 9 8
LEVOTHYROXINE SODIUM 434 383 10 2
AMLODIPINE BESYLATE 427 352 11 3
CLOPIDOGREL 411 345 12 29
FLUTICASONE PROPIONATE 405 337 13 35
CRESTOR 398 272 14 27
PLAVIX 383 329 15 37
LOSARTAN POTASSIUM 360 306 16 12
GABAPENTIN 345 251 17 14
SOLARAZE 310 231 18 177
ATENOLOL 310 246 18 11
EXELON 303 255 20 63
METOPROLOL TARTRATE 274 226 21 7
DOVONEX 273 171 10 22 207
FUROSEMIDE 261 232 23 6
LANTUS 259 176 24 47
CELEBREX 259 166 24 110
ABILIFY 253 170 26 135
MONTELUKAST SODIUM 251 193 27 120
DIOVAN 240 175 28 33
KETOCONAZOLE 238 183 29 151
CARVEDILOL 238 193 29 22
ZOLPIDEM TARTRATE 231 200 31 17
NAMENDA 231 189 31 20
NOVOLIN 70-30 231 180 31 158
ALENDRONATE SODIUM 223 196 34 26
DICLOFENAC SODIUM 220 171 35 109
CLOTRIMAZOLE-BETAMETHASONE 217 170 36 100
CLONIDINE HCL 217 116 36 52
DONEPEZIL HCL 212 172 38 15
HYDROCHLOROTHIAZIDE 207 141 39 13
OLANZAPINE 207 114 39 129
VOLTAREN 190 127 41 116
TAMSULOSIN HCL 188 170 42 30
COMBIVENT 188 153 42 161
RANITIDINE HCL 182 158 44 32
TRAMADOL HCL 178 133 45 24
POTASSIUM CHLORIDE 177 140 46 19
INSULIN SYRINGE 173 125 47 96
GLIPIZIDE 173 167 47 43
WARFARIN SODIUM 172 153 49 9
ALPRAZOLAM 169 141 50 41
TRIAMCINOLONE ACETONIDE 169 144 50 143
SYMBICORT 163 126 52 181
ESCITALOPRAM OXALATE 161 140 53 40
CYMBALTA 148 87 54 62
PROAIR HFA 148 112 54 71
DIOVAN HCT 143 133 56 92
VESICARE 140 118 57 223
NOVOLOG 134 120 58 76
SPIRIVA 133 66 59 90
TRICOR 131 90 60 172
ISOSORBIDE MONONITRATE ER 130 123 61 55
LANSOPRAZOLE 128 100 62 118
METOPROLOL SUCCINATE 126 103 63 21
TEMAZEPAM 121 121 64 49
GLYBURIDE-METFORMIN HCL 118 61 R 65 107
AMMONIUM LACTATE 118 72 65 173
AZITHROMYCIN 117 98 67 36
DIGOXIN 115 101 68 39
PANTOPRAZOLE SODIUM 114 93 69 34
ATORVASTATIN CALCIUM 112 90 70 16
LYRICA 111 56 71 120
AVODART 111 111 71 169
ENALAPRIL MALEATE 110 98 73 38
VIAGRA 108 105 74 74
LEXAPRO 105 79 75 105
OXYCODONE HCL-ACETAMINOPHEN 105 27 S2 75 122
SURE COMFORT 103 84 77 174
FINASTERIDE 103 100 77 70
HYDRALAZINE HCL 100 76 79 84
CHLORHEXIDINE GLUCONATE 100 46 79 279
PATADAY 99 85 81 280
MELOXICAM 96 60 82 57
METOCLOPRAMIDE HCL 95 68 83 139
FLUOXETINE HCL 95 95 83 98
CALCIPOTRIENE 94 48 10 85 281
MECLIZINE HCL 90 73 86 86
PAROXETINE HCL 89 68 87 54
ECONAZOLE NITRATE 89 65 87 285
GEMFIBROZIL 89 67 87 104
INVEGA 88 63 90 287
DOXAZOSIN MESYLATE 87 85 91 77
NAPROXEN 85 58 92 93
TRIAMTERENE-HCTZ 85 75 92 68
LOVAZA 82 59 94 125
LOSARTAN-HYDROCHLOROTHIAZIDE 81 69 95 59
AMLODIPINE BESYLATE-BENAZEPRIL 81 60 95 89
LACTULOSE 76 73 97 101
PREDNISONE 76 67 97 45
ACTOS 75 65 99 178
SEROQUEL XR 74 59 100 199
OXYCODONE-ACETAMINOPHEN 74 47 S2 100 66
CLOBETASOL PROPIONATE 74 65 100 211
SORIATANE 73 48 10 103 298
NIFEDIPINE ER 73 54 103 83
MUPIROCIN 72 61 105 130
ZYPREXA 72 44 105 259
ATRIPLA 71 25 107 301
GLYBURIDE 66 60 R 108 75
AZELASTINE HCL 65 49 109 309
FENOFIBRATE 64 51 110 61
BENICAR 63 47 111 144
ALLOPURINOL 63 47 111 42
MEGACE ES 63 59 R 111 318
MEGESTROL ACETATE 62 61 R 114 148
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 38 115 56
PENTOXIFYLLINE 61 48 115 191
PEN NEEDLE 60 32 117 186
RESTASIS 59 40 118 275
SUCRALFATE 58 53 119 190
LANTUS SOLOSTAR 57 32 120 133
VERAPAMIL ER 57 25 120 112
HYDROCODONE-ACETAMINOPHEN 55 42 S3 122 10
CIPROFLOXACIN HCL 54 46 123 51
NITROSTAT 54 41 123 242
NOVOLOG MIX 70-30 51 36 125 196
LIPITOR 50 45 126 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.